LEMAITRE VASCULAR, INC.

Lemaitre Vascular, Inc. specializes in the design, manufacturing, and supply of advanced vascular surgical implants and medical devices, with deep expertise in venous and arterial allografts, cryopreserved vascular tissues, and prosthetic graft systems. The company’s technical capabilities center on biologic tissue processing, sterile implant manufacturing, and precision vascular graft engineering, serving critical needs in vascular reconstruction and bypass procedures. Their products—including saphenous vein allografts, cryo-vein implants, and femoral artery prosthetics—reflect a focused specialization in vascular access solutions that meet stringent clinical and regulatory standards for implantable medical devices. Differentiators include proprietary preservation techniques for vascular tissues and a commitment to biocompatible, anatomically accurate implant designs tailored for long-term patency and surgical integration. The company maintains a consistent and primary relationship with the Department of Veterans Affairs, delivering specialized vascular implants used in peripheral arterial disease treatment, revascularization, and limb salvage programs. These procurements reflect a trusted, recurring partnership where the VA relies on Lemaitre Vascular for mission-critical, high-complexity surgical supplies that support veteran-specific vascular care pathways. Lemaitre Vascular operates primarily within NAICS 339112 (Surgical and Medical Instrument Manufacturing) and 339113 (Surgical Appliance and Supplies Manufacturing), positioning itself as a niche supplier of implantable vascular grafts and biologic surgical devices. The company’s market focus is firmly on interventional vascular surgery, serving the intersection of tissue engineering, minimally invasive procedures, and implantable medical device innovation. As a 2L entity headquartered in Burlington, Massachusetts, Lemaitre Vascular, Inc. is a manufacturer-driven organization with no government certifications on record. Its geographic and operational footprint is centered on U.S. federal healthcare procurement channels, with a strategic emphasis on serving the Veterans Health Administration through reliable, clinically validated vascular implant solutions.